Floseal Reduces the Incidence of Lymphoceles After Lymphadenectomies in Laparoscopic and Robot-Assisted Extraperitoneal Radical Prostatectomy
- 1 June 2011
- journal article
- research article
- Published by SAGE Publications in Journal of Endourology
- Vol. 25 (6) , 969-973
Abstract
Purpose: To evaluate the efficacy and cost-effectiveness of FloSeal® hemostatic matrix in preventing lymphocele development after pelvic lymphadenectomy (PLA). Materials and Methods: This was a single-center, matched comparison of lymphadenectomies in laparoscopic and robot-assisted extraperitoneal radical prostatectomy (ERP) performed with and without FloSeal between January 2008 and October 2009. FloSeal was applied topically in the lymphadenectomy zone immediately after node resection. Cost analysis for lymphocele treatment was performed. Results: A total of 142 patients underwent PLA with ERP (32 with FloSeal, 110 without FloSeal). The mean number of lymph nodes removed was 6.5±4.5 (range 2–20). Median prostate-specific antigen concentration was 8.5 ng/mL (range 1.5–24 ng/mL). There was one (3.1%) symptomatic lymphocele in the FloSeal group compared with 16 (14.5%) in the non-FloSeal group. The median number of lymph nodes removed was 8 (range 5–20) in the FloSeal group and seven (range 3–25) in the non-FloSeal group. The only lymphocele in the FloSeal group was treated with percutaneous drainage alone. In the non-FloSeal group, six symptomatic lymphoceles were managed conservatively—four with percutaneous puncture and six with fenestration after percutaneous drainage. The mean cost per patient of treating symptomatic lymphoceles was €327 ($455) in the FloSeal group (total costs €10,481 [$14,559]) vs €553 ($769) (total costs €60,870 [$84,551]) in the non-FloSeal group. Conclusions: These preliminary data suggest that the use of FloSeal after lymphadenectomy can reduce the number of symptomatic lymphoceles and is cost-effective.Keywords
This publication has 28 references indexed in Scilit:
- The Use of a Surgical Patch in the Prevention of Lymphoceles After Extraperitoneal Pelvic Lymphadenectomy for Prostate Cancer: A Randomized Prospective Pilot StudyJournal of Urology, 2009
- Complications of Pelvic Lymphadenectomy in 1,380 Patients Undergoing Radical Retropubic Prostatectomy Between 1993 and 2006Journal of Urology, 2008
- Complications of endoscopic extraperitoneal radical prostatectomy (EERPE): prevention and managementWorld Journal of Urology, 2006
- Detection of Pelvic Lymph Node Metastases in Patients With Clinically Localized Prostate Cancer: Comparison of [ 18 F]Fluorocholine Positron Emission Tomography-Computerized Tomography and Laparoscopic Radioisotope Guided Sentinel Lymph Node DissectionJournal of Urology, 2006
- Complications and Other Surgical Outcomes Associated with Extended Pelvic Lymphadenectomy in Men with Localized Prostate CancerEuropean Urology, 2006
- The incidence and treatment of lymphoceles after radical retropubic prostatectomyBJU International, 2005
- Frequency of Lymphoceles after Open and Laparoscopic Pelvic Lymph Node Dissection in Patients with Prostate CancerScandinavian Journal of Urology and Nephrology, 2003
- Intraoperative and Perioperative Morbidity of Contemporary Radical Retropubic Prostatectomy in a Consecutive Series of 1243 Patients: Results of a Single Center between 1999 and 2002European Urology, 2003
- Laparoscopic pelvic lymph node dissection allows significantly more accurate staging in “high‐risk” prostate cancer compared to MRI or CTScandinavian Journal of Urology and Nephrology, 2003
- INTRAOPERATIVE AND POSTOPERATIVE COMPLICATIONS OF RADICAL RETROPUBIC PROSTATECTOMY IN A CONSECUTIVE SERIES OF 1,000 CASESJournal of Urology, 2001